DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-799 Cr |
| Mar2024 | ₹-799 Cr |
| Mar2023 | ₹-797 Cr |
| Mar2022 | ₹-532 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-799 Cr | Negative | |
| Mar2024 | ₹-799 Cr | Negative | |
| Mar2023 | ₹-797 Cr | Negative | |
| Mar2022 | ₹-532 Cr | Negative | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹169,635.9 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹90,069.9 Cr | -0.3% | -3% | -24.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.9% |
-1.6% |
11.1% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses